Metabolic modeling of gut microbiota in high-fat diet-induced nonalcoholic steatohepatitis through barrier dysfunction and shaping of intrahepatic immunity are ameliorated by VSL#3 supplementation

NIAID Data Ecosystem30

Data_Sheet_1_Group 3 Innate Lymphoid Cells Protect Steatohepatitis From High-Fat Diet Induced Toxicity.PDF

非酒精性脂肪性肝炎

固有淋巴样细胞3型保护机制

Background and Aims: Emerging evidence has revealed that innate lymphoid cells (ILCs) play a key role in regulating metabolic disorders. Here, we investigated the role of group 3 ILCs (ILC3s) in the m

NIAID Data Ecosystem30

DataSheet3_Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice.ZIP

非酒精性脂肪性肝炎

糖尿病药物

Nonalcoholic fatty liver disease (NAFLD), which is the most common liver disease, is associated with type 2 diabetes mellitus and metabolic syndrome. Although there is no consensus on the treatment of

NIAID Data Ecosystem30

FLCN Gene Ablation Reduces Fibrosis and Inflammation in a Diet-Induced NASH Model

非酒精性脂肪性肝炎

细胞自噬调控

Non-alcoholic steatohepatitis (NASH) represents a major economic burden and is characterized by triglyceride accumulation, inflammation, and fibrosis. No pharmacological agents are currently approved

NIAID Data Ecosystem30

Dataset associated with: "Diosgenin alleviates nonalcoholic steatohepatitis through affecting liver-gut circulation"

资源简介：

相关数据集